Skip to main content
Industry News
Experimental HIV injection just as effective administered bi-monthly

ViiV Healthcare, a GlaxoSmithKline unit, unveiled data from its trial that showed its injection formula of cabotegravir and rilpivirine as a treatment for HIV was just as effective given bi-monthly as it is administered once a month. The injection not only reduces the treatment frequency but also helps patients who cannot take daily pills.

Full Story: